Manufacturer Recalls Coumadin Tablets

May 12, 2011 12:42 PM

Bristol-Myers Squibb has initiated a voluntary recall of one lot of 1,000-count bottles of Coumadin^® (warfarin) 5-mg tablets due to the possible presence of high potency tablets. The recall was initiated as a precautionary measure because one tablet in a tested bottle of returned Coumadin was found to be higher in potency than expected. The affected lot is number 9H49374A, with an expiration date of September 30, 2012, and affected bottles have been distributed to pharmacies. Bristol-Myers Squibb recommends that patients who have 5-mg Coumadin tablets not interrupt their therapy. Instead, they should contact their pharmacist to determine if their tablets originated from the recalled lot and, if so, consult their physician for appropriate medical advice. More information about the recall is available on the FDA Web site.